Author

A. Rouvinski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1

Frequent Co-Authors

L. Baraz· 3 shared M. Stolovich-Rain· 3 shared A. Friedman· 2 shared D. G. Wolf· 2 shared D. Padawer· 2 shared E. Cohen-Kfir· 2 shared M. Billan· 2 shared M. Elgrably-Weiss· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

L. Baraz

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Primary bovine white blood cells support dissemination of Lumpy Skin Disease Virus while suppressing viral replication

M. Kumar, O. Frid, A. Sol, A. Rouvinski, S. Karniely

This study shows that primary bovine white blood cells support LSDV dissemination but suppress viral replication, with heat-treated virus inducing antiviral gene expression.

bioRxiv · Jul 18, 2024 · PreprintMicrobiology

Binding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition

J. Fahoum, M. Billan, J. K. Varga, D. Padawer, M. Elgrably-Weiss, P. Basu, M. Stolovich-Rain, L. Baraz, S. Kumari, E. Oiknine-Dijan, M. Kumar, E. Cohen-Kfir, O. Zelig, G. Mayer, M. N. Isupov, , A. Rouvinski

This study shows that SARS-CoV-2 nucleocapsid protein binds to uninfected cells, triggering antibody-mediated complement activation in COVID-19 patients.

bioRxiv · Mar 17, 2024 · PreprintImmunology

Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA

M. Stolovich-Rain, S. Kumari, A. Friedman, S. Kirillov, Y. Socol, M. Billan, R. Ranjan Pal, P. Golding, E. Oiknine-Djian, S. Sirhan, M. Bejerano Sagie, E. Cohen-Kfir, M. Elgrably-Weiss, B. Zhou, M. Ravins, , A. Rouvinski

This study shows that the BNT162b2 mRNA vaccine induces temporary salivary IgA with strong neutralizing activity against SARS-CoV-2.

Frontiers in Immunology · Jan 30, 2023Peer-reviewedMicrobiology

Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of Nsp1, Nsp2, and Nucleocapsid proteins from SARS-CoV-2

M. Slavin, J. Zamel, K. Zohar, S. Eliyahu, M. Braitbard, E. Brielle, L. Baraz, M. Stolovich-Rain, A. Friedman, D. G. Wolf, A. Rouvinski, M. Linial, D. Schneidman-Duhovny, N. Kalisman

This study uses targeted in situ CLMS and integrative modeling to determine the structures of SARS-CoV-2 Nsp1, Nsp2, and N proteins, revealing key interactions and functional insights.

bioRxiv · Feb 4, 2021Biochemistry